Advertisement
UK markets close in 8 hours 1 minute
  • FTSE 100

    8,131.13
    +52.27 (+0.65%)
     
  • FTSE 250

    19,689.99
    +88.01 (+0.45%)
     
  • AIM

    754.98
    +1.86 (+0.25%)
     
  • GBP/EUR

    1.1651
    -0.0006 (-0.05%)
     
  • GBP/USD

    1.2502
    -0.0009 (-0.07%)
     
  • Bitcoin GBP

    51,651.39
    +238.00 (+0.46%)
     
  • CMC Crypto 200

    1,386.93
    -9.61 (-0.69%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • CRUDE OIL

    84.14
    +0.57 (+0.68%)
     
  • GOLD FUTURES

    2,351.80
    +9.30 (+0.40%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,652.90
    +368.36 (+2.13%)
     
  • DAX

    18,019.16
    +101.88 (+0.57%)
     
  • CAC 40

    8,045.21
    +28.56 (+0.36%)
     

Enanta Pharmaceuticals: Fiscal 1Q Earnings Snapshot

Enanta Pharmaceuticals: Fiscal 1Q Earnings Snapshot

WATERTOWN, Mass. (AP) _ Enanta Pharmaceuticals Inc. (ENTA) on Wednesday reported fiscal first-quarter net income of $26 million.

The Watertown, Massachusetts-based company said it had net income of $1.25 per share.

The results did not meet Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of $1.46 per share.

The biotechnology company posted revenue of $69.9 million in the period, which also missed Street forecasts. Four analysts surveyed by Zacks expected $73.1 million.

Enanta Pharmaceuticals shares have risen 19 percent since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $84.01, a fall of roughly 9 percent in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ENTA at https://www.zacks.com/ap/ENTA